Eagle Pharmaceuticals, Inc.
USD0.67
+0.07 (+11.67%)
CEO
Michael Graves
IPO Date
2014-02-12
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTC
Country
US
Open
$0.58
Prev. Close
$0.60
Day Low
$0.58
Day High
$0.67
52W Low
$0.09
52W High
$3.87
Market Cap
$0.01B
Volume
0.00M
| 31 Dec 2021 | FY | 75.4% | -5.0% | -4.9% | -3.4% | 0.17 | 2.32 | -77.0 |
| 31 Dec 2020 | FY | 75.8% | 6.4% | 6.4% | 4.7% | 0.21 | 4.36 | 52.4 |
| 31 Dec 2019 | FY | 68.9% | 7.3% | 8.0% | 5.6% | 0.22 | 4.62 | 57.7 |
| 31 Dec 2018 | FY | 71.0% | 15.0% | 19.8% | 13.4% | 0.28 | 4.13 | 18.7 |
| 31 Dec 2017 | FY | 75.8% | 21.9% | 29.0% | 19.2% | 0.27 | 3.99 | 15.5 |
| 31 Dec 2016 | FY | 70.8% | 43.0% | 53.9% | 38.1% | 0.00 | 2.71 | 15.1 |
| 31 Dec 2015 | FY | 76.4% | 3.9% | 2.8% | 2.1% | 0.00 | 3.57 | 526.0 |
| 30 Sept 2014 | FY | 38.7% | -94.1% | -54.3% | -33.7% | 0.00 | 2.61 | -7.0 |
| 16.1 |
| 31 Dec 2022 | Q4 | 67.3% | 13.5% | 3.5% | 2.0% | 0.27 | 1.70 | 11.6 |
| 30 Sept 2022 | Q3 | 64.1% | -5.3% | -1.5% | -0.9% | 0.26 | 1.52 | -24.8 |
| 30 Jun 2022 | Q2 | 68.1% | -12.7% | -4.0% | -2.5% | 0.23 | 1.78 | -15.1 |
| 31 Mar 2022 | Q1 | 76.0% | 38.0% | 20.4% | 13.8% | 0.13 | 2.36 | 3.6 |
| 31 Dec 2021 | Q4 | 70.9% | -14.6% | -3.5% | -2.4% | 0.15 | 2.32 | -26.5 |
| 30 Sept 2021 | Q3 | 79.3% | -14.1% | -3.0% | -2.2% | 0.17 | 3.55 | -32.4 |
| 30 Jun 2021 | Q2 | 77.6% | 7.5% | 1.9% | 1.4% | 0.17 | 3.93 | 38.8 |
| 31 Mar 2021 | Q1 | 73.7% | -1.0% | -0.2% | -0.2% | 0.19 | 3.91 | -323.9 |